相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。COVID-19 vaccine: where are we now and where should we go?
Saman Soleimanpour et al.
EXPERT REVIEW OF VACCINES (2021)
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles
Caroline B. Plescia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Coronavirus 2019-nCoV: A brief perspective from the front line
Qingmei Han et al.
JOURNAL OF INFECTION (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Rotavirus VP6 Adjuvant Effect on Norovirus GII.4 Virus-Like Particle Uptake and Presentation by Bone Marrow-Derived Dendritic Cells In Vitro and In Vivo
Kirsi Tamminen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
Hongzhou Lu
BIOSCIENCE TRENDS (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
A novel rapid modularized hepatitis B core virus-like particle-based platform for personalized cancer vaccine preparation via fixed-point coupling
Mei Ji et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Recent Progress on the Versatility of Virus-Like Particles
Ciying Qian et al.
VACCINES (2020)
Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications
Young Hun Chung et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Improving immunogenicity and safety of flagellin as vaccine carrier by high-density display on virus-like particle surface
Yiwen Zhao et al.
BIOMATERIALS (2020)
Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
Ruodan Xu et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Next-generation vaccine platforms for COVID-19
Debby van Riel et al.
NATURE MATERIALS (2020)
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Ugur Sahin et al.
NATURE (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Minimal system for assembly of SARS-CoV-2 virus like particles
Heather Swann et al.
SCIENTIFIC REPORTS (2020)
COVID-19: Coronavirus Vaccine Development Updates
Jing Zhao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
Paulina N. Naupu et al.
VACCINES (2020)
Production of influenza virus-like particles using recombinant insect cells
Takuya Matsuda et al.
BIOCHEMICAL ENGINEERING JOURNAL (2020)
Advances in influenza virus-like particles bioprocesses
Laurent Durous et al.
EXPERT REVIEW OF VACCINES (2019)
Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B. S. Roden et al.
NATURE REVIEWS CANCER (2018)
MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques
Chong Wang et al.
ONCOTARGET (2017)
Production of virus-like particles for vaccines
J. Fuenmayor et al.
NEW BIOTECHNOLOGY (2017)
Tumour virus vaccines: hepatitis B virus and human papillomavirus
Margaret Stanley
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2017)
Major findings and recent advances in virus like particle (VLP)-based vaccines
Mona O. Mohsen et al.
SEMINARS IN IMMUNOLOGY (2017)
Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice
Xinya Lu et al.
IMMUNOLOGY (2007)
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system
E Mortola et al.
FEBS LETTERS (2004)
分享论文
